Issue Date: Apr 26, 2012
The Indian drug manufacturing company Ranbaxy Laboratories Limited launched a new anti-malarial drug, Synriam on the occasion of World Malaria Day on April 25.
The drug, a combination of arterolane maleate 150 mg and piperaquine phosphate 750 mg, is now available in the market. An adult suffering from malaria will need only one tablet a day for three days. In case of other malaria medicines two to four tablets are required, twice daily for three or more days. The new drug regime will lead to better compliance, says Ranbaxy.